Fresenius Medical Care AG (NYSE:FMS) Short Interest Up 6.9% in October

Fresenius Medical Care AG (NYSE:FMS - Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 730,200 shares, a growth of 6.9% from the September 30th total of 683,300 shares. Based on an average daily volume of 294,500 shares, the days-to-cover ratio is presently 2.5 days.

Fresenius Medical Care Stock Up 1.1 %

Shares of FMS traded up $0.22 during midday trading on Friday, reaching $19.76. The stock had a trading volume of 469,613 shares, compared to its average volume of 371,051. The company has a market cap of $11.60 billion, a price-to-earnings ratio of 20.37, a PEG ratio of 0.93 and a beta of 0.91. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.46 and a quick ratio of 1.09. The company's fifty day simple moving average is $20.33 and its two-hundred day simple moving average is $20.18. Fresenius Medical Care has a 1-year low of $16.66 and a 1-year high of $22.76.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $0.38 earnings per share for the quarter, hitting analysts' consensus estimates of $0.38. Fresenius Medical Care had a net margin of 2.72% and a return on equity of 5.48%. The firm had revenue of $5.13 billion during the quarter, compared to analysts' expectations of $5.28 billion. Equities research analysts expect that Fresenius Medical Care will post 1.52 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Allworth Financial LP lifted its holdings in shares of Fresenius Medical Care by 53.1% in the third quarter. Allworth Financial LP now owns 1,675 shares of the company's stock valued at $36,000 after purchasing an additional 581 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Fresenius Medical Care by 50.4% during the 3rd quarter. GAMMA Investing LLC now owns 4,998 shares of the company's stock valued at $106,000 after acquiring an additional 1,675 shares in the last quarter. ORG Wealth Partners LLC purchased a new stake in shares of Fresenius Medical Care in the third quarter worth about $112,000. ORG Partners LLC acquired a new stake in Fresenius Medical Care in the first quarter valued at approximately $110,000. Finally, SageView Advisory Group LLC acquired a new stake in Fresenius Medical Care during the 1st quarter valued at $127,000. Hedge funds and other institutional investors own 8.25% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have commented on FMS. Truist Financial upped their price objective on Fresenius Medical Care from $22.00 to $23.00 and gave the stock a "hold" rating in a research report on Monday, October 7th. StockNews.com assumed coverage on Fresenius Medical Care in a research note on Friday. They issued a "strong-buy" rating on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Fresenius Medical Care currently has a consensus rating of "Hold" and a consensus price target of $23.00.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.